Japan's Otsuka to Acquire U.S. Firm Astex for $886M

Otsuka seeks to increase revenue streams as patents for its mainstay Abilify schizophrenia treatment will begin to expire
Sept. 5, 2013
Japanese drugmaker Otsuka Holdings Co. has agreed to buy Astex Pharmaceuticals Inc. for about $886 million to tap cancer drugs under development by the U.S. biotechnology company. Read the full story
Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates

Related

Eli Lilly’s new Concord, North Carolina site was built with NASCAR-like speed
Celltrion to buy US biologics manufacturing plant as part of tariff response strategy
OnTrak Wireless: Total Bearing Health Solution
Sponsored
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
Sponsored